FDA Licenses First-Ever Freeze-Dried Plasma Product for Emergency Use
The U.S. Food and Drug Administration (FDA) has licensed Ezplaz Freeze Dried Plasma (FDP), marking it as the first freeze-dried plasma product approved for use in the United States. Ezplaz is designed for transfusion in adult patients who require plasma and for whom other plasma products are unavailable. This product is particularly beneficial in emergency situations such as combat zones, disasters, and rural settings where traditional hospital infrastructure is lacking. Unlike conventional plasma products that require freezing and thawing, Ezplaz can be stored at room temperature and is rapidly reconstituted, making it suitable for austere environments. The FDA's decision addresses a significant unmet medical need, especially for military personnel and others in remote areas. 
